Meagan Medical Inc. Announces Issuance of a Key U.S. Patent for a Disruptive Chronic Pain Treatment using Spinal Cord Stimulation
FOR IMMEDIATE RELEASE
Patent provides protection for High Frequency Spinal Cord Stimulation with Beat Technology
Vancouver, Washington – March 20, 2015 – Meagan Medical Inc., a clinical research and medical device development company focused on investigating and developing optimal ways of managing and controlling pain, announced today the issuance of a key patent related to a unique way of stimulating the spinal cord.
U.S. Patent No. 8,977,363 includes multiple system claims for delivering high frequency stimulation to the spinal cord with base frequencies between 500 Hz to 20 kHz while generating a directionally controllable beat frequency between 0-250 Hz.
“We believe that this patent and technology will dramatically affect and improve outcomes for patients suffering from chronic back and leg pain that are candidates for spinal cord stimulation” said Meagan Medical’s Executive Vice President and Chief Scientific Officer, Bill Carroll. “This technology will afford all the benefits of High Frequency Spinal Cord Stimulation plus the added ability to direct and control the higher beat output toward the dorsal column. “
Additional patent applications for this technology are pending.
About Meagan Medical
Privately held Meagan Medical, headquartered in Vancouver, WA, is a clinical research and medical device development company and is the research arm and sister company of RS Medical. Meagan Medical is committed to vigorously pursuing research and collaborative relationships in the areas of pain control, spinal cord stimulation and a variety of other neurological applications of electrostimulation therapy. More information at www.meaganmedical.com or call Bill Carroll at (360) 891-7290.